Senior insider sale
Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC — senior position signals high conviction
$3.75M
21.20K shares
What this filing means
DELAET INGRID plans to sell 21.20K shares of NEUROCRINE BIOSCIENCES INC valued at approximately $3.75M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/10/2026ACC: 0001950047-26-007015
Officer· Chief Regulatory Officer
Since Feb 2026
21.20K
Shares to sell
$3.75M
Approx. market value
4.37K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
7/10/2026
4.37KTotal acquired4.37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/10/2026 | Exercise of Stock Options Cash | 4.37K | — |
| Total | 4.37K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
8.43K
Market value
$1.51M
7/9/2026
—Completed
Units to sell
2.74K
Market value
$488.7K
7/8/2026
—Completed
Units to sell
3.40K
Market value
$607.3K
7/7/2026
—Completed
Units to sell
2.26K
Market value
$354.3K
5/29/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.37K
Market value
$788.5K
7/10/2026
Total
Units
21.20K
Value
$3.75M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/9/2026 | 8.43K | $1.51M | — | Completed |
7/8/2026 | 2.74K | $488.7K | — | Completed |
7/7/2026 | 3.40K | $607.3K | — | Completed |
5/29/2026 | 2.26K | $354.3K | — | Completed |
| Planned — Approximate Date | ||||
7/10/2026 | 4.37K | $788.5K | NASDAQ | Planned |
| Total | 21.20K | $3.75M | ||